Needham & Company LLC Forecasts Strong Price Appreciation for Cognex (NASDAQ:CGNX) Stock

Key Points

• Needham raised Cognex’s price target from $75 to $80 while maintaining a “buy” rating, implying 14.55% potential upside. Cantor Fitzgerald also lifted its target to $84, and analysts collectively hold a “Moderate Buy” consensus rating.
• Cognex reported quarterly EPS of $0.45, beating the $0.42 estimate, while revenue rose 16.9% year over year to $291.3 million despite narrowly missing expectations. The company’s full-year 2026 EPS guidance of $1.64–$1.68 exceeds the current analyst forecast of $1.48.
• Insider selling remains a cautionary signal: insiders sold roughly 224,847 shares worth $15.0 million over the past 90 days, while institutional investors own 88.12% of the stock.

Cognex (NASDAQ:CGNX - Get Free Report) had its target price boosted by research analysts at Needham & Company LLC from $75.00 to $80.00 in a report released on Friday,Benzinga reports. The firm presently has a "buy" rating on the scientific and technical instruments company's stock. Needham & Company LLC's price objective would suggest a potential upside of 14.55% from the company's current price.

Other analysts have also recently issued research reports about the stock. Zacks Research upgraded shares of Cognex from a "hold" rating to a "strong-buy" rating in a report on Tuesday, June 16th. Citigroup restated a "neutral" rating on shares of Cognex in a report on Friday. Cantor Fitzgerald raised their target price on shares of Cognex from $76.00 to $84.00 and gave the stock an "overweight" rating in a research report on Friday. UBS Group set a $75.00 target price on shares of Cognex in a research note on Tuesday, May 26th. Finally, Sanford C. Bernstein reiterated an "outperform" rating and set a $75.00 price target on shares of Cognex in a research report on Thursday, May 7th. Two research analysts have rated the stock with a Strong Buy rating, ten have assigned a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $75.69.

Cognex Price Performance

CGNX opened at $69.84 on Friday. Cognex has a one year low of $34.60 and a one year high of $72.88. The business has a 50 day simple moving average of $64.99 and a two-hundred day simple moving average of $57.09. The firm has a market capitalization of $11.62 billion, a price-to-earnings ratio of 67.56 and a beta of 1.49.

Cognex (NASDAQ:CGNX - Get Free Report) last issued its quarterly earnings data on Wednesday, August 5th. The scientific and technical instruments company reported $0.45 earnings per share for the quarter, topping analysts' consensus estimates of $0.42 by $0.03. Cognex had a return on equity of 13.82% and a net margin of 16.05%.The firm had revenue of $291.26 million for the quarter, compared to analyst estimates of $292.10 million. During the same period last year, the company earned $0.25 EPS. The business's quarterly revenue was up 16.9% compared to the same quarter last year. Cognex has set its FY 2026 guidance at 1.640-1.680 EPS and its Q3 2026 guidance at 0.500-0.540 EPS. As a group, sell-side analysts expect that Cognex will post 1.48 EPS for the current fiscal year.

Insiders Place Their Bets

In other Cognex news, VP Darren Marc Long sold 20,252 shares of the stock in a transaction on Wednesday, May 27th. The stock was sold at an average price of $66.34, for a total value of $1,343,517.68. Following the completion of the transaction, the vice president owned 3,990 shares in the company, valued at approximately $264,696.60. This represents a 83.54% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Mark Fennell sold 64,873 shares of the firm's stock in a transaction on Monday, May 11th. The shares were sold at an average price of $67.05, for a total value of $4,349,734.65. Following the transaction, the insider directly owned 11,263 shares of the company's stock, valued at $755,184.15. This represents a 85.21% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders sold 224,847 shares of company stock worth $14,975,098. 1.70% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Cognex

Hedge funds have recently bought and sold shares of the business. Intech Investment Management LLC boosted its stake in Cognex by 124.5% in the 4th quarter. Intech Investment Management LLC now owns 98,451 shares of the scientific and technical instruments company's stock worth $3,542,000 after purchasing an additional 54,600 shares in the last quarter. One Capital Management LLC purchased a new stake in Cognex during the 4th quarter valued at about $1,945,000. Handelsbanken Fonder AB increased its stake in Cognex by 76.3% during the 4th quarter. Handelsbanken Fonder AB now owns 758,831 shares of the scientific and technical instruments company's stock valued at $27,303,000 after purchasing an additional 328,427 shares in the last quarter. Allspring Global Investments Holdings LLC bought a new stake in Cognex during the 4th quarter valued at about $753,000. Finally, Legal & General Group Plc raised its holdings in Cognex by 11.1% in the fourth quarter. Legal & General Group Plc now owns 1,152,053 shares of the scientific and technical instruments company's stock worth $41,451,000 after buying an additional 114,652 shares during the last quarter. Institutional investors own 88.12% of the company's stock.

Key Headlines Impacting Cognex

Here are the key news stories impacting Cognex this week:

• Positive Sentiment: Analysts raised price targets: Cantor Fitzgerald increased its target from $76 to $84 and upgraded or maintained an “overweight” rating, implying approximately 22% upside from the referenced price. Truist Financial raised its target from $71 to $78 while retaining a “hold” rating. Benzinga analyst rating reports Ticker Report analyst coverage
• Positive Sentiment: Quarterly earnings beat expectations: Cognex reported second-quarter EPS of $0.45, above the $0.42 consensus and up from $0.25 a year earlier. Revenue reached a record $291.3 million, increasing 16.9% year over year, while margin gains, favorable product mix and cost controls supported the earnings outperformance. Cognex Q2 earnings beat report
• Positive Sentiment: Outlook was raised materially: Third-quarter revenue guidance of $300 million to $320 million and EPS guidance of $0.50 to $0.54 are well above consensus estimates. Full-year 2026 EPS guidance of $1.64 to $1.68 also exceeds the $1.48 analyst estimate, reinforcing expectations for continued industrial automation demand. Cognex second-quarter results
• Neutral Sentiment: Revenue slightly missed estimates: Quarterly revenue of roughly $291 million was just below the $292.1 million consensus, but the miss was offset by stronger margins and earnings. The company also declared a quarterly dividend of $0.085 per share, representing a modest yield of about 0.5%.
• Negative Sentiment: Insider selling is a cautionary signal: Reported insider activity over the past six months showed 16 sales and no purchases. Institutional positioning was mixed, with some major investors reducing holdings while others added shares, limiting the strength of the ownership signal.

Cognex Company Profile

Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.

The company's product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source